Ariane L. Herrick

Oxford Road
Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 250 publications

Influence of comorbidities and patient demographics on Raynaud's symptom characteristics: implications for diagnosis and management.

Influence of comorbidities and patient demographics on Raynaud's symptom characteristics: implications for diagnosis and management.

Journal: Journal of scleroderma and related disorders

Published: April 09, 2026

Identifying candidate core domains for clinical trials in systemic sclerosis-associated Raynaud's phenomenon and digital ulcers.

Identifying candidate core domains for clinical trials in systemic sclerosis-associated Raynaud's phenomenon and digital ulcers.

Journal: Seminars in arthritis and rheumatism

Published: February 10, 2026

Refining Human Phenotype Ontology (HPO) to enable better phenotype-genotype integration in systemic autoimmune rheumatic diseases.

Refining Human Phenotype Ontology (HPO) to enable better phenotype-genotype integration in systemic autoimmune rheumatic diseases.

Journal: Orphanet journal of rare diseases

Published: January 26, 2026

Systemic Sclerosis-Recent Advances in Diagnosis and Management.

Systemic Sclerosis-Recent Advances in Diagnosis and Management.

Journal: British journal of hospital medicine (London, England : 2005)

Published: December 24, 2025

Feasibility study of a smartphone app to monitor systemic sclerosis-related digital ulcers-a potential new tool for remote clinical monitoring.

Feasibility study of a smartphone app to monitor systemic sclerosis-related digital ulcers-a potential new tool for remote clinical monitoring.

Journal: Rheumatology advances in practice

Published: December 23, 2025

The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosis.

The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosis.

Journal: Rheumatology (Oxford, England)

Published: December 15, 2025

Novel HLA class I and II insights into the pathogenesis of systemic sclerosis-associated interstitial lung disease.

Novel HLA class I and II insights into the pathogenesis of systemic sclerosis-associated interstitial lung disease.

Journal: Annals of the rheumatic diseases

Published: December 11, 2025

Novel pleiotropic loci links vascular and immune pathways in systemic sclerosis and primary Raynaud's phenomenon.

Novel pleiotropic loci links vascular and immune pathways in systemic sclerosis and primary Raynaud's phenomenon.

Journal: Rheumatology (Oxford, England)

Published: October 27, 2025

Novel pleiotropic loci link vascular and immune pathways in systemic sclerosis and primary Raynaud's phenomenon.

Novel pleiotropic loci link vascular and immune pathways in systemic sclerosis and primary Raynaud's phenomenon.

Journal: Rheumatology (Oxford, England)

Published: October 27, 2025

A randomised open-label pilot trial comparing mycophenolate mofetil with no immunosuppression in limited cutaneous systemic sclerosis (MINIMISE-Pilot).

A randomised open-label pilot trial comparing mycophenolate mofetil with no immunosuppression in limited cutaneous systemic sclerosis (MINIMISE-Pilot).

Journal: Rheumatology (Oxford, England)

Published: October 19, 2025

Assessing digital vasculopathy in systemic sclerosis.

Assessing digital vasculopathy in systemic sclerosis.

Journal: Rheumatology (Oxford, England)

Published: September 27, 2025

Distinct Effects of Complement C4A and C4B Copy Numbers in Systemic Sclerosis Serological and Clinical Subtypes.

Distinct Effects of Complement C4A and C4B Copy Numbers in Systemic Sclerosis Serological and Clinical Subtypes.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: June 26, 2025

Showing 1-12 of 250

Last Updated: 09/26/2026